Implications of the HELIX trial for treating infants with hypoxic ischaemic encephalopathy in low-to-middle-income countries

Davidson, Joanne; Battin, malcolm; Gunn, Alistair

dc.contributor.author	Davidson, Joanne
dc.contributor.author	Battin, malcolm
dc.contributor.author	Gunn, Alistair
dc.date.accessioned	2022-03-03T01:18:55Z
dc.date.available	2022-03-03T01:18:55Z
dc.date.issued	2022-2-28
dc.identifier.citation	Archives of disease in childhood. Fetal and neonatal edition 21 Feb 2022
dc.identifier.issn	1359-2998
dc.identifier.uri	https://hdl.handle.net/2292/58371
dc.publisher	BMJ
dc.relation.ispartofseries	Archives of Disease in Childhood: Fetal and Neonatal Edition
dc.rights	Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri	https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri	https://creativecommons.org/licenses/by-nc/4.0/
dc.subject	1114 Paediatrics and Reproductive Medicine
dc.title	Implications of the HELIX trial for treating infants with hypoxic ischaemic encephalopathy in low-to-middle-income countries
dc.type	Journal Article
dc.date.updated	2022-02-08T03:35:06Z
dc.rights.holder	Copyright: The author	en
dc.rights.accessrights	http://purl.org/eprint/accessRights/OpenAccess	en
pubs.subtype	Article
pubs.elements-id	882534